Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(36%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
1
9%
Ph not_applicable
10
91%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Recruiting3
Active, not recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (9.1%)
N/A10 (90.9%)

Trials by Status

recruiting327%
active_not_recruiting19%
completed545%
unknown19%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11